Argo Biopharma inks $5.2 billion deal with Novartis for novel molecules for cardiovascular diseases
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
India has taken the lead in recognising NAFLD as a major non-communicable disease
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Subscribe To Our Newsletter & Stay Updated